$1.11 Billion is the total value of General Catalyst Group Management, LLC's 15 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 13.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Samsara, Inc. | $572,463,000 | +8.1% | 47,428,587 | 0.0% | 52.76% | +11.8% | ||
| Sell | GitLab, Inc. | $108,658,000 | -34.3% | 2,121,405 | -31.9% | 10.01% | -32.1% | |
| Catalyst Partners Acquisition Corp. | $76,217,000 | +1.1% | 7,714,286 | 0.0% | 7.02% | +4.6% | ||
| Warby Parker Inc. | $75,459,000 | +18.5% | 5,656,571 | 0.0% | 6.95% | +22.5% | ||
| OSCR | Oscar Health, Inc. | $72,180,000 | +17.4% | 14,464,995 | 0.0% | 6.65% | +21.5% | |
| XM | Qualtrics International, Inc. | $44,153,000 | -18.6% | 4,337,186 | 0.0% | 4.07% | -15.8% | |
| Evolv Techology Holdings, Inc. | $28,188,000 | -20.3% | 13,296,148 | 0.0% | 2.60% | -17.5% | ||
| HAAC | Health Assurance Acquisition Cor. | $23,070,000 | +1.0% | 2,311,624 | 0.0% | 2.13% | +4.5% | |
| BIGC | BigCommerce Holdings, Inc. | $17,760,000 | -8.6% | 1,200,000 | 0.0% | 1.64% | -5.5% | |
| LMND | Sell | Lemonade, Inc. | $17,086,000 | -37.9% | 806,722 | -46.5% | 1.58% | -35.7% |
| Cazoo Group LTD | $15,836,000 | -36.1% | 34,426,357 | 0.0% | 1.46% | -33.9% | ||
| New | Wag! Group Co | $14,302,000 | – | 6,976,530 | +100.0% | 1.32% | – | |
| REVH | Buy | Revolution Healthcare Acquisition Corp. | $12,017,000 | +4.6% | 1,223,750 | +4.5% | 1.11% | +8.2% |
| OPRT | Oportun Financial Corp. | $4,128,000 | -47.2% | 944,556 | 0.0% | 0.38% | -45.4% | |
| VRM | Vroom, Inc. | $3,540,000 | -7.2% | 3,051,670 | 0.0% | 0.33% | -4.1% | |
| TDOC | Exit | Teladoc Health, Inc. | $0 | – | -581,347 | -100.0% | -1.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BigCommerce Holdings, Inc. | 12 | Q3 2023 | 18.5% |
| Lemonade, Inc. | 12 | Q3 2023 | 10.8% |
| Vroom, Inc. | 12 | Q3 2023 | 8.5% |
| Oscar Health, Inc. | 11 | Q3 2023 | 15.0% |
| Warby Parker Inc. | 9 | Q3 2023 | 26.0% |
| Evolv Techology Holdings, Inc. | 9 | Q3 2023 | 5.2% |
| Samsara, Inc. | 8 | Q3 2023 | 74.1% |
| GitLab, Inc. | 8 | Q3 2023 | 14.7% |
| Teladoc Health, Inc. | 7 | Q2 2022 | 55.0% |
| Cazoo Group LTD | 7 | Q1 2023 | 13.6% |
View General Catalyst Group Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-04-14 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-09 |
| 3 | 2022-08-09 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-02-14 |
View General Catalyst Group Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.